Tag: cx 2024
Scientific and societal backing for multimodality topical oxygen therapy herald “new...
A roundtable discussion at the 2024 Charing Cross (CX) Symposium (23–25 April, London, UK) saw a multidisciplinary panel of experts discuss a new multimodal...
Long-term IN.PACT AV data show there is “definitely a place” for...
Matteo Tozzi (Varese, Italy) and Kate Steiner (Stevenage, UK) sat down with Vascular News at this year’s Charing Cross (CX) International Symposium (23–25 April,...
IN.PACT AV Access five-year results strengthen physicians’ conviction on applying DCB...
Alexander Mallios (Paris, France) and Andrew Holden (Auckland, New Zealand; one of the co-chairs of the Charing Cross Symposium) share their views on...
Angioplasty with novel, easy-to-use, bladed Flex Vessel Prep system “could replace...
Robert Shahverdyan (Hamburg, Germany) encourages interventionalists to try the new Flex Vessel Prep system (VentureMed) to experience the benefits that arrive in the wake...
First-time presentation of IN.PACT AV Access five-year data lays paclitaxel mortality...
Andrew Holden (Auckland, New Zealand), one of the co-chairs of the Charing Cross (CX) International Symposium, presented the final five-year data on the vital...
Vascular News 102 – June 2024: North American Edition
In this issue:
Common ground: High-quality data and individualised care emerge as non-negotiables in CX 2024 aortic debates
Studies highlight need for tailored treatment...
Vascular News 102 – June 2024: European Edition
In this issue:
Common ground: High-quality data and individualised care emerge as non-negotiables in CX 2024 aortic debates
Studies highlight need for tailored treatment...
Learning in the workplace: Fostering a culture of reciprocity is key
Our Launch Pad columnist Sarah Sillito (Newcastle, UK), who ran the Rouleaux Club Introduction to Vascular Surgery Course at the recent Charing Cross (CX)...
Who, why and where: Experts address key questions on the future...
L-R: Dittmar Böckler, Eric Verhoeven and Hence Verhagen
“Centralisation and interdisciplinary teams—they are the keys,” Dittmar Böckler (University Hospital Heidelberg, Heidelberg, Germany) concluded during...
GORE® TAG® Thoracic Branch Endoprosthesis “meets an area of major need”
This advertorial, sponsored by Gore, is only available in selected countries and geographies.
The GORE TAG Thoracic Branch Endoprosthesis (TBE) recently became the first...
New frontiers in LSA preservation: Dedicated symposium at CX 2024 spotlights...
This advertorial, sponsored by Gore, is only available in selected countries and geographies.
A satellite session at the 2024 Charing Cross (CX) International Symposium...
New randomised data show cyanoacrylate glue performs strongly on patient satisfaction
Patients undergoing cyanoacrylate glue closure for superficial venous disease reported higher periprocedural satisfaction than those who were treated via surgical stripping, data from a...
CX 2024: Worrying Foot Competition winners announced
Following audience polling, Nathalie Yonan (Newcastle upon Tyne, United Kingdom) and Balraj Maan (Willington, United Kingdom) were announced as the winners of the Worrying...
Study finds dedicated clinics achieve higher rate of amputation-free survival in...
Presenting podium-first data on specialist chronic limb-threatening ischaemia (CLTI) clinics and rates of amputation, Assad Khan (Leeds, United Kingdom) provided an argument for “favourable”...
Interim analysis provides early window into real-world Alto stent graft outcomes
In a podium-first presentation on the final day of the 2024 Charing Cross (CX) International Symposium (23–25 April, London, UK), Sean Lyden (Cleveland Clinic,...
New data highlight rising incidence of aortic dissection in England
“The incidence of acute aortic dissection in England is rising,” Arun Pherwani (University Hospitals of North Midlands NHS Trust, Stoke-on-Trent, UK) told the 2024...
Questions linger: BASIL-3 does not find for drug-eluting technologies for CLTI
In the UK National Institute for Health and Care Research (NIHR) Health Technology Assessment (HTA)-funded BASIL-3 randomised controlled trial (RCT), neither drug-coated balloon (DCB)...
REBOA: Is balloon use in emergency trauma really just hot air?
Balloon occlusion is one of the most hotly contested topics when it comes to vascular surgery in the setting of emergency trauma and, with...
“We know which DCB to use”—but many other questions remain in...
A first-time presentation at the 2024 Charing Cross (CX) International Symposium (23–25 April, London, UK) of five-year data from the IN.PACT AV Access study...
Cross-sectional survey study reveals long-term health-related QoL after acute type B...
During today’s (Tuesday) Aortic Techniques & Technologies session, Hence Verhagen (Rotterdam, Netherlands) delivered a podium-first presentation on long-term health-related quality of life (HRQoL) after...
CX 2024: Paclitaxel device restrictions “did cause harm”
“Unfortunately, we are doing worse for our patients today,” were the sobering thoughts of Eric Secemsky (Boston, United States) during a late-breaking presentation in...
CX 2024 venous programme has “a lot to look forward to,”...
Erin Murphy (Atrium Health’s Sanger Heart and Vascular Institute, Charlotte, USA), one of the CX Symposium cochairs and a CX Executive Board member, along...
Debates to unpick controversies in aortic repair at CX 2024
Debates will shed new light on controversies in the treatment of aortic disease at the 2024 Charing Cross (CX) Symposium, alongside practical sessions with...
Vascular News – CX Special Edition 2024 (North America)
Issue highlights:
Endovascular showdown: CX 2024 sets the stage for BASIL-3 first-time data presentations
A year in profiles: Rachel Bell, Jürgen Falkensammer, Peter Schneider,...
Vascular News – CX Special Edition 2024 (Europe)
Issue highlights:
Endovascular showdown: CX 2024 sets the stage for BASIL-3 first-time data presentations
A year in profiles: Rachel Bell, Jürgen Falkensammer, Peter Schneider,...
Why treat DVT interventionally with a “wall-to-wall” mechanical thrombectomy approach?
In a recent interview, Marie Josee van Rijn from Rotterdam, the Netherlands and Emma Wilton from Oxford, UK, provided insight into the transformative power...
Endovascular showdown: CX 2024 sets the stage for BASIL-3 first-time data...
At the Charing Cross (CX) Symposium 2024 (23–25 April, London, UK), Andrew Bradbury (University of Birmingham, Birmingham, UK) and the BASIL-3 team of triallists...
Vascular News 100 – November 2023 US Edition
In this issue:
Obituary: Roger M Greenhalgh 6th February 1941 – 6th October 2023
Forty five-year legacy of CX vascular education continues: The new CX...
Vascular News 100 – November 2023
In this issue:
Obituary: Roger M Greenhalgh 6th February 1941 – 6th October 2023
Forty five-year legacy of CX vascular education continues: The new...
